Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury
about
Protective effect of total aralosides of Aralia elata (Miq) Seem (TASAES) against diabetic cardiomyopathy in rats during the early stage, and possible mechanisms.Enhanced skeletal muscle expression of extracellular superoxide dismutase mitigates streptozotocin-induced diabetic cardiomyopathy by reducing oxidative stress and aberrant cell signaling.Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidantsInterplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathyDiabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelationAcceleration of diabetic-wound healing with PEGylated rhaFGF in healing-impaired streptozocin diabetic rats.Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation.Zinc-induced cardiomyocyte relaxation in a rat model of hyperglycemia is independent of myosin isoform.Zinc protects against diabetes-induced pathogenic changes in the aorta: roles of metallothionein and nuclear factor (erythroid-derived 2)-like 2.Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, alphavbeta3-integrin, and TGF-beta1 in response to ANG II and high glucoseDiabetes and the heart: could the diabetic myocardium be protected by preconditioning?Diabetes, metallothionein, and zinc interactions: a review.Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetesInactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodelingTissue 65Zinc translocation in a rat model of chronic aldosteronism.Role of apoptosis in cardiovascular disease.Metallothionein Prevents Age-Associated Cardiomyopathy via Inhibiting NF-κB Pathway Activation and Associated Nitrative Damage to 2-OGD.Oxidative stress, diabetes, and diabetic complications.Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.Oxidative stress and myocardial injury in the diabetic heartThe role of zinc in the prevention of diabetic cardiomyopathy and nephropathy.Zinc homeostasis in the metabolic syndrome and diabetes.Pathophysiological Fundamentals of Diabetic Cardiomyopathy.Metallothionein rescues hypoxia-inducible factor-1 transcriptional activity in cardiomyocytes under diabetic conditions.Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism.Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression.Curcumin ameliorates streptozotocin-induced heart injury in rats.Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection.Metallothionein prevents diabetes-induced cardiac pathological changes, likely via the inhibition of succinyl-CoA:3-ketoacid coenzyme A transferase-1 nitration at Trp(374).Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice.
P2860
Q29346973-39AFA060-53AB-4039-9825-91DE9F66D6AEQ30301118-8FA9E4D5-C820-47F9-9D07-640629AE700DQ33572265-7C16091B-787A-447E-A961-0BE3049BBA42Q33589104-4F99A751-4A95-4C1D-A173-6607458F69A4Q33804265-F9BCFFEB-6496-41CC-9D4D-B37D49AA490CQ34076711-5AAD519B-ECE9-4086-AB11-2916AB3F5BF9Q36289400-31FB81EC-5923-49ED-BB48-3454C2C75814Q36510174-12B4B9D6-B3AC-44B8-B3E5-5045632AD759Q36753482-3A00D5DE-85A2-40D0-9A95-C9F437B7BF97Q36807947-C1F9C643-5A1F-446E-84BA-B02732273322Q36981806-6A322DB8-3804-49A7-B76A-C50E418D04ECQ37023703-33BEEDDD-DBCE-4163-8A3E-DB4F9E563703Q37100174-6E911819-1934-42CC-9111-818C20469AF1Q37193667-815D2B07-A57A-4E15-9098-18FBA28A310DQ37263925-98E1D62E-C186-4907-8E33-0462F71CABF6Q37368042-D2AC48D5-6779-4BEE-9DEB-C1EF504DC749Q37485286-969D6DFB-879A-44A2-9B16-910B99495159Q37613032-B2F56057-CCAD-4A9A-9119-7DF2599E2508Q37902643-1C74DA72-4A26-498C-8BCA-D31AFB040161Q38046547-ED6B3CB0-AE57-47E8-92EF-F60D3726D556Q38049642-18FEF468-D845-4DCD-9E52-C2465F965EEFQ38079445-FFBDFA03-3DC6-4947-BB47-A6973DDFE7BCQ39195672-177EDF1B-D026-4DD5-94A2-02AD959BF132Q40116408-4FBD56CD-489A-43FD-BEA4-9FA87F50C81CQ42056161-80CBF521-8D9C-4850-9BA5-623885772F90Q42457139-73136F26-AF21-4F66-88A5-1C007D1BC63EQ42705885-8DF75F42-7BF5-4E5D-BC27-0BA291B593AEQ42906132-FA379208-BE3E-4AE7-9BDD-2268D2E5C7E9Q43809822-57DBD4AE-CB4E-461E-B5A0-068624EA806BQ45775555-07A58B2C-DBDC-4E40-B695-D3B17D6655AF
P2860
Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cardiac metallothionein synthe ...... iabetes-induced cardiac injury
@ast
Cardiac metallothionein synthe ...... iabetes-induced cardiac injury
@en
type
label
Cardiac metallothionein synthe ...... iabetes-induced cardiac injury
@ast
Cardiac metallothionein synthe ...... iabetes-induced cardiac injury
@en
prefLabel
Cardiac metallothionein synthe ...... iabetes-induced cardiac injury
@ast
Cardiac metallothionein synthe ...... iabetes-induced cardiac injury
@en
P2093
P2860
P1476
Cardiac metallothionein synthe ...... iabetes-induced cardiac injury
@en
P2093
Gavin E Arteel
Jack T Saari
Jianxun Wang
Y James Kang
P2860
P356
10.1016/S0002-9440(10)62949-5
P407
P577
2005-07-01T00:00:00Z